HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arnon Nagler Selected Research

Lymphoma (Lymphomas)

1/2024Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
12/2023Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
1/2023Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma.
12/2021Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.
1/2021Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma.
1/2021Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment.
1/2020Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study.
12/2019CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives.
12/2019Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
10/2019Early and late hematologic toxicity following CD19 CAR-T cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arnon Nagler Research Topics

Disease

224Leukemia
05/2024 - 01/2002
192Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 01/2002
98Graft vs Host Disease (Graft-Versus-Host Disease)
05/2024 - 12/2002
98Neoplasms (Cancer)
01/2024 - 01/2002
71Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2024 - 01/2002
59Multiple Myeloma
05/2023 - 12/2002
36Hematologic Neoplasms (Hematological Malignancy)
12/2023 - 03/2002
27Lymphoma (Lymphomas)
01/2024 - 08/2003
24BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 01/2002
22Infections
04/2024 - 12/2002
21Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2023 - 12/2007
18Pathologic Complete Response
05/2024 - 10/2004
17B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 11/2007
17Bronchiolitis Obliterans Syndrome
11/2021 - 08/2002
13Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 01/2002
10Neoplasm Metastasis (Metastasis)
10/2018 - 12/2002
9Chromosome Aberrations (Chromosome Abnormalities)
01/2024 - 10/2007
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 01/2008
9Philadelphia Chromosome
01/2021 - 04/2006
9Fibrosis (Cirrhosis)
01/2013 - 07/2003
8Hodgkin Disease (Hodgkin's Disease)
12/2023 - 06/2003
8Disease Progression
12/2022 - 03/2007
8Residual Neoplasm
12/2020 - 01/2004
7Primary Myelofibrosis (Myelosclerosis)
11/2021 - 12/2009
7Inflammation (Inflammations)
01/2021 - 08/2009
7Melanoma (Melanoma, Malignant)
01/2020 - 03/2006
6Hematologic Diseases (Blood Diseases)
01/2021 - 01/2013
6Thrombocytopenia (Thrombopenia)
07/2020 - 06/2010
6Blast Crisis (Blast Phase)
10/2019 - 01/2002
6Neutropenia
10/2019 - 08/2003
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 01/2012
4Communicable Diseases (Infectious Diseases)
04/2024 - 01/2016
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2019 - 01/2002

Drug/Important Bio-Agent (IBA)

68Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2024 - 10/2013
36fludarabineIBA
12/2023 - 12/2002
32Busulfan (Busulfex)FDA Link
10/2023 - 01/2003
29Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
05/2024 - 12/2002
22Chimeric Antigen ReceptorsIBA
12/2023 - 09/2014
19halofuginoneIBA
06/2015 - 05/2002
14Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
12/2023 - 01/2016
14treosulfanIBA
10/2023 - 12/2007
14Bortezomib (Velcade)FDA Link
12/2020 - 04/2006
12Melphalan (Alkeran)FDA LinkGeneric
12/2023 - 12/2002
12Proteins (Proteins, Gene)FDA Link
05/2023 - 01/2002
12heparanaseIBA
01/2023 - 01/2002
11Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2024 - 01/2003
11Tyrosine Kinase InhibitorsIBA
01/2022 - 06/2010
11Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2021 - 01/2004
11Imatinib Mesylate (Gleevec)FDA Link
05/2014 - 10/2004
10Methotrexate (Mexate)FDA LinkGeneric
04/2024 - 01/2003
10AntigensIBA
04/2024 - 03/2003
10AntibodiesIBA
01/2020 - 05/2002
10CollagenIBA
11/2012 - 05/2002
9LigandsIBA
01/2019 - 06/2005
8Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2024 - 03/2016
8HLA Antigens (Human Leukocyte Antigens)IBA
11/2022 - 11/2008
6SteroidsIBA
01/2024 - 12/2002
6CytokinesIBA
10/2023 - 04/2010
6tisagenlecleucelIBA
12/2022 - 01/2019
6Rituximab (Mabthera)FDA Link
01/2018 - 08/2003
6Azacitidine (5 Azacytidine)FDA Link
04/2017 - 05/2010
6Collagen Type I (Type I Collagen)IBA
02/2007 - 07/2003
5Calcineurin InhibitorsIBA
04/2024 - 03/2016
5Immunoglobulins (Immunoglobulin)IBA
12/2023 - 07/2009
5Interleukin-15 (Interleukin 15)IBA
10/2023 - 08/2003
5Lenalidomide (CC 5013)FDA Link
01/2021 - 04/2008
5Dexamethasone (Maxidex)FDA LinkGeneric
12/2020 - 01/2012
5GlobulinsIBA
02/2020 - 01/2003
5Monoclonal AntibodiesIBA
01/2019 - 01/2003
51-dodecylpyridoxal (PLD)IBA
07/2016 - 09/2007
5liposomal doxorubicin (Doxil)FDA Link
07/2016 - 09/2007
5BKT140IBA
05/2014 - 03/2011
4IronIBA
12/2023 - 07/2014
4Thomsen-Friedenreich antibodiesIBA
02/2020 - 01/2003
4Sorafenib (BAY 43-9006)FDA Link
03/2019 - 01/2018
4RNA (Ribonucleic Acid)IBA
01/2019 - 01/2002
4EnzymesIBA
10/2018 - 09/2008
4AlkaloidsIBA
06/2015 - 01/2011
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2015 - 09/2004
4Thalidomide (Thalomid)FDA Link
09/2014 - 11/2004
4Interleukin-2 (IL2)IBA
09/2013 - 05/2009
4Transforming Growth Factor beta (TGF-beta)IBA
01/2011 - 09/2008
4Interleukin-12 (IL 12)IBA
09/2004 - 03/2003
3Tacrolimus (Prograf)FDA LinkGeneric
04/2024 - 10/2020

Therapy/Procedure

219Transplantation
05/2024 - 08/2002
165Stem Cell Transplantation
05/2024 - 01/2002
99Hematopoietic Stem Cell Transplantation
04/2024 - 01/2002
96Therapeutics
01/2024 - 03/2002
84Cell Transplantation
04/2024 - 02/2013
48Drug Therapy (Chemotherapy)
03/2024 - 01/2002
27Immunotherapy
12/2023 - 01/2002
23Haploidentical Transplantation
05/2024 - 04/2015
22Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2022 - 08/2002
21Homologous Transplantation
04/2024 - 01/2002
9Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2022 - 04/2004
7Salvage Therapy
07/2023 - 03/2008
6Autologous Transplantation
01/2023 - 01/2010
5Cell- and Tissue-Based Therapy (Cell Therapy)
01/2013 - 03/2006
4Hematopoietic Stem Cell Mobilization
09/2021 - 01/2014
4Radiotherapy
01/2018 - 05/2005